Disc Col

Similar articles

Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer.[Ann Surg Oncol. 2015]
Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer.
Cooper AB, Slack R, Fogelman D, Holmes HM, Petzel M, Parker N, Balachandran A, Garg N, Ngo-Huang A, Varadhachary G, et al. Ann Surg Oncol. 2015 Jul; 22(7):2416-23. Epub 2014 Dec 18.
Role of neoadjuvant therapy in the multimodality treatment of older patients with pancreatic cancer.[J Am Coll Surg. 2014]
Role of neoadjuvant therapy in the multimodality treatment of older patients with pancreatic cancer.
Cooper AB, Holmes HM, des Bordes JK, Fogelman D, Parker NH, Lee JE, Aloia TA, Vauthey JN, Fleming JB, Katz MH. J Am Coll Surg. 2014 Jul; 219(1):111-20. Epub 2014 Mar 13.
Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.[Ann Surg Oncol. 2014]
Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
Rose JB, Rocha FG, Alseidi A, Biehl T, Moonka R, Ryan JA, Lin B, Picozzi V, Helton S. Ann Surg Oncol. 2014 May; 21(5):1530-7. Epub 2014 Jan 29.
Review Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies.[Ann Surg Oncol. 2012]
Review Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies.
Andriulli A, Festa V, Botteri E, Valvano MR, Koch M, Bassi C, Maisonneuve P, Sebastiano PD. Ann Surg Oncol. 2012 May; 19(5):1644-62. Epub 2011 Oct 20.
Review Neoadjuvant therapy for resectable pancreatic cancer.[Surg Oncol Clin N Am. 2004]
Review Neoadjuvant therapy for resectable pancreatic cancer.
Raut CP, Evans DB, Crane CH, Pisters PW, Wolff RA. Surg Oncol Clin N Am. 2004 Oct; 13(4):639-61, ix.

See reviews...See all...

Cited by 7 PubMed Central articles

Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma.[Cancer. 2016]
Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma.
Cloyd JM, Crane CH, Koay EJ, Das P, Krishnan S, Prakash L, Snyder RA, Varadhachary GR, Wolff RA, Javle M, et al. Cancer. 2016 Sep 1; 122(17):2671-9. Epub 2016 May 31.
Review Current and Emerging Clinical Applications of Multispectral Optoacoustic Tomography (MSOT) in Oncology.[Clin Cancer Res. 2016]
Review Current and Emerging Clinical Applications of Multispectral Optoacoustic Tomography (MSOT) in Oncology.
McNally LR, Mezera M, Morgan DE, Frederick PJ, Yang ES, Eltoum IE, Grizzle WE. Clin Cancer Res. 2016 Jul 15; 22(14):3432-9. Epub 2016 May 20.
Review Management of borderline resectable pancreatic cancer.[World J Gastrointest Oncol. 2015]
Review Management of borderline resectable pancreatic cancer.
Mahipal A, Frakes J, Hoffe S, Kim R. World J Gastrointest Oncol. 2015 Oct 15; 7(10):241-9.

See all...

Save items

Similar articles

Cited by 7 PubMed Central articles

Related information

Recent Activity